# DSIP FAQ: Direct Answers on the Delta Sleep-Inducing Peptide

> DSIP questions answered directly and cited: what it is, whether it helps you fall asleep, how it affects delta EEG, how it feels, side effects, and what recent research shows.

Short, specific answers — cited where there is a number, honest where there isn't.

## What is DSIP peptide?

DSIP (delta sleep-inducing peptide) is a natural nine-amino-acid peptide, sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It was isolated in 1977 from the blood of sleeping rabbits and named because, when infused into the brain, it produced a significant, specific enhancement of delta and spindle EEG activity — the brain waves of deep sleep [1]. No specific DSIP receptor has been identified.

## What is DSIP peptide used for?

In practice DSIP is used only in research, with sleep the dominant interest. Its name comes from enhancing delta and spindle EEG activity in the 1977 isolation study [1]. It has also been investigated for chronic insomnia [2], pain, and withdrawal, plus animal work on stress hormones and neuroprotection. It is not approved by any regulator for any use.

## How does DSIP make you feel?

Community reports vary widely. Among people who respond, the common description is an easier wind-down, deeper-feeling sleep, vivid dreams, and waking clear-headed rather than groggy — anecdotal reports, not clinical findings. A large share report feeling nothing at all. In the controlled human data, 25 nmol/kg intravenously produced no daytime sedation, with sleep benefits emerging in the second hour [2].

## Does DSIP help you fall asleep?

The small human evidence points to better sleep rather than rapid sleep onset. In six chronic insomniacs, 25 nmol/kg intravenously lengthened sleep and reduced interruptions, but the effect appeared in the second hour after injection, with slight arousal in the first [2]. Community accounts describe it as nudging an existing sleep drive, not forcing sleep like a sedative.

## How does DSIP affect delta sleep and the EEG?

DSIP is named for its EEG effect: the 1977 study showed infusing it enhanced delta and spindle activity [1]. In rats it raised neocortical and limbic delta EEG power by roughly 35%, with more frequent theta bursts and changes sustained up to 11 hours [9]. "Delta" is the slow, high-amplitude brain-wave band of deep sleep.

## What is the best peptide for sleeping?

There is no evidence-based "best" sleep peptide; this site covers only DSIP and does not rank or compare products. DSIP itself has a real delta-EEG signature [1] but inconsistent human results — a 2006 review called its sleep evidence weak [3]. Persistent sleep problems warrant evaluation by a qualified professional, not a research chemical.

## What are people's DSIP results and experiences?

Reported experiences split sharply. Responders describe deeper sleep, vivid dreams, and clear-headed mornings; many others report no effect, and some report headache, unpredictable timing, or next-day grogginess. These are anecdotal community reports, not measured outcomes. The formal record is small old human pilots [2] plus stronger animal EEG data [9], with no modern replication [3].

## What are the benefits of DSIP peptide?

The pursued benefits are all sleep-related: faster wind-down, deeper sleep, feeling more rested. The supporting evidence is a 1977 delta-EEG signature [1], a ~35% rise in rat delta power [9], and small human studies showing better sleep at 25 nmol/kg [2][7]. None has been confirmed in a modern controlled trial, so these are best read as promising but unestablished [3].

## Does DSIP really work?

Honestly, inconsistently. The animal EEG data is fairly robust (~35% rat delta-power increase [9]), and small 1980s human trials reported real sleep gains [2][7]. But a 2006 review judged the sleep evidence "extremely poorly documented and still weak" [3], and a large share of users report no effect. There is no large modern trial settling the question.

## Does DSIP make you tired?

Not in the knockout sense people often expect. In the human data, 25 nmol/kg intravenously produced no daytime sedation [2], and community reports describe it as supporting sleep rather than forcing drowsiness. A minority do report next-day grogginess or unpredictable, delayed sedation — including one forum account of sedation arriving the following day. Responses are highly individual.

## How long does it take for DSIP peptide to work?

In the main human study, the sleep-promoting effect of 25 nmol/kg intravenously emerged in the second hour after injection, with a slight arousal in the first hour [2]. So even where it works, it is not described as instant. Community reports on timing are mixed and sometimes describe delayed or next-day effects.

## How long does it take for DSIP to kick in?

The controlled human evidence points to a delayed onset: sleep benefits at 25 nmol/kg intravenously appeared in the second hour after the dose, not the first [2]. Some community accounts report effects on the same night, others describe unpredictable timing. There is no validated human pharmacokinetic profile to give a precise onset window.

## Does DSIP work immediately?

The human data argues against an immediate effect: in the key study, 25 nmol/kg intravenously produced a slight arousal in the first hour and the sleep benefit only in the second [2]. Community reports are inconsistent on timing. Given the lack of a validated human pharmacokinetic profile, no reliable immediate-onset claim can be made.

## How long before bed should you take DSIP?

This site gives no dosing or timing instructions. As a research observation only: the human sleep effect at 25 nmol/kg intravenously emerged in the second hour after administration [2], and community accounts emphasize that timing felt sensitive and sometimes unpredictable. Timing has not been studied in any modern controlled trial.

## How long can you take DSIP for?

There is no established duration, because there is essentially no long-term human safety data — human study is limited to small, mostly 1980s pilot trials [2]. Some community reports describe the effect diminishing with consecutive nightly use, which is why anecdotal protocols lean toward intermittent use. This is not guidance; long-term use has not been characterized.

## How long does DSIP peptide stay in your system?

Very briefly. An enzyme-immunoassay clearance study in dogs, monkeys, and rats reported plasma half-lives of only a few minutes, due to rapid breakdown by aminopeptidases. Even so, peripherally given DSIP reaches the central nervous system — subcutaneous DSIP increased slow-wave sleep in cats [10]. No validated human pharmacokinetic profile exists.

## Is DSIP habit forming?

There is no controlled human study establishing dependence or withdrawal for DSIP, so this is genuinely uncharacterized. Notably, in one phase-shifted-insomnia report DSIP was associated with complete withdrawal from a hypnotic medication [8]. The honest answer is that DSIP's abuse and dependence potential has not been studied; absence of data is not proof of safety.

## What are the side effects of DSIP peptide?

The most commonly reported side effect, in both community accounts and the older clinical literature, is a mild, transient headache. Mild nausea, dizziness, or lightheadedness are reported less often. Some report unpredictable timing or next-day grogginess. These are anecdotal reports, not measured incidence rates — no controlled human safety trial of DSIP exists [3].

## Does DSIP affect growth hormone?

In rats, DSIP has been reported to raise growth hormone through a dopamine-dependent (pimozide-sensitive) hypothalamic pathway. But this did not reproduce in human women, where studies found no growth-hormone or prolactin effect. So the GH effect is a cross-species inconsistency, not an established human action — one more reason DSIP's biology is considered unresolved [3].

## Does DSIP raise cortisol or affect stress hormones?

In men, intravenous DSIP at 25 nmol/kg reduced plasma ACTH-like immunoreactivity for at least three hours while cortisol followed its normal daily decline [4] — a selective HPA-axis touch that lowered ACTH without raising cortisol. However, this early finding was not reproduced in every later human study, so a consistent stress-hormone effect is not established [3].

## Is DSIP neuroprotective?

Animal work suggests possible neuroprotection — including mitochondrial and oxidative-stress protection under experimental hypoxia, and a 2024 fusion-peptide study that increased hippocampal neuron density in insomnia-model mice [6]. These are preclinical findings in animals, not demonstrated human neuroprotection. As with DSIP's other proposed roles, the human evidence is absent.

## What does recent research say about DSIP?

The notable recent work is a 2024 study of a DSIP fusion peptide engineered to cross the blood-brain barrier (DSIP-CBBBP), which cut average daily wakefulness from about 720 to about 500 minutes (~31%) in insomnia-model mice, restored melatonin, serotonin, and dopamine, and outperformed native DSIP [6]. It reinforces the long-standing pattern that engineered analogs, not native DSIP, drive the clearest effects [3].

---

A data-forward digest of the delta sleep-inducing peptide literature — every figure sourced, every gap named, and no clinic, vendor, or prescription behind the numbers.